Find a Researcher
Wonsuk Yoo, PhD, is an associate professor of translational neuroscience and director of the Ivy Brain Tumor Center Biostatistics Program in the Department of Translational Neuroscience at Barrow Neurological Institute. He also leads the Biostatistics Core.
He has expertise in drug discovery, population-based cancer research, and preclinical and clinical trial design. He is a member of the American Association for Cancer Research, the American Statistics Association, and the American Public Health Association.
Dr. Yoo earned his Master of Science degree in statistics from the University of Florida in Gainesville and his Doctor of Philosophy degree in biostatistics from the Medical University of South Carolina in Charleston.
Dr. Yoo’s research interests include the development of statistical and quantitative approaches and performing collaborative research to develop a novel approach to solve problems in clinical trials and observational studies. His current research focuses on the evaluation of phase 0 paradigms in brain tumor trials, the determination of threshold methods for pharmacokinetic and pharmacodynamic biomarkers, novel study design of phase 0 trigger trials using two-stage designs, and population-based, data-driven research using public-access big data (SEER, NHANES, TCGA, CMS, BioLINCC, etc).
- PhD, Medical University of South Carolina, Biostatistics
- Predoctoral Internship, Wyeth Pharmaceutical Research
- MS, University of Florida, Statistics
- BS, Yonsei University, Applied Statistics
- American Association for Cancer Research
- American Statistical Association
- American Public Health Association
- Travel Scholarship Award, American Association for Cancer Research, Cancer Biostatistics Workshop, 2009
- Young Investigator’s Award, American Statistics Association, Statistics in Epidemiology Section, 2005
Quisinostat is a brain-penetrant radiosensitizer in glioblastoma
Date: 11/2023
Authors: Costanza Lo Cascio, Tigran Margaryan, Ernesto Luna-Melendez, James B. McNamara, Connor I. White, William Knight, Saisrinidhi Ganta, Zorana Opachich, Claudia Cantoni, Wonsuk Yoo, Nader Sanai, Artak Tovmasyan, Shwetal Mehta
Rapid whole-brain myelin imaging with selective inversion recovery and compressed SENSE
Date: 03/2023
Authors: Ping Wang, Nicholas Sisco, Wonsuk Yoo, Aimee Borazanci, John Karis, J. P. Karis, John P Karis, Richard Dortch
Evaluation of two-stage designs of Phase 2 single-arm trials in glioblastoma: a systematic review
Date: 12/2022
Authors: Wonsuk Yoo, Seongho Kim, Michael Garcia, Shwetal Mehta, Nader Sanai
A Phase 0 Trial of Ceritinib in Patients with Brain Metastases and Recurrent Glioblastoma
Date: 01/2022
Authors: Shwetal Mehta, Roberto Fiorelli, Xun Bao, Chelsea Pennington-Krygier, Alanna Derogatis, Seongho Kim, Wonsuk Yoo, Jing Li, Nader Sanai
Human papillomavirus vaccine guideline adherence among Arizona's Medicaid beneficiaries
Date: 01/2021
Authors: Alexis Koskan, Lynne Klasko-Foster, Chad Stecher, Sue Rodriguez, Deborah Helitzer, Wonsuk Yoo
Wonsuk Yoo, PhD, is an associate professor of translational neuroscience and director of the Ivy Brain Tumor Center Biostatistics Program in the Department of Translational Neuroscience at Barrow Neurological Institute. He also leads the Biostatistics Core.
He has expertise in drug discovery, population-based cancer research, and preclinical and clinical trial design. He is a member of the American Association for Cancer Research, the American Statistics Association, and the American Public Health Association.
Dr. Yoo earned his Master of Science degree in statistics from the University of Florida in Gainesville and his Doctor of Philosophy degree in biostatistics from the Medical University of South Carolina in Charleston.
Dr. Yoo’s research interests include the development of statistical and quantitative approaches and performing collaborative research to develop a novel approach to solve problems in clinical trials and observational studies. His current research focuses on the evaluation of phase 0 paradigms in brain tumor trials, the determination of threshold methods for pharmacokinetic and pharmacodynamic biomarkers, novel study design of phase 0 trigger trials using two-stage designs, and population-based, data-driven research using public-access big data (SEER, NHANES, TCGA, CMS, BioLINCC, etc).
- PhD, Medical University of South Carolina, Biostatistics
- Predoctoral Internship, Wyeth Pharmaceutical Research
- MS, University of Florida, Statistics
- BS, Yonsei University, Applied Statistics
- American Association for Cancer Research
- American Statistical Association
- American Public Health Association
- Travel Scholarship Award, American Association for Cancer Research, Cancer Biostatistics Workshop, 2009
- Young Investigator’s Award, American Statistics Association, Statistics in Epidemiology Section, 2005
Quisinostat is a brain-penetrant radiosensitizer in glioblastoma
Date: 11/2023
Authors: Costanza Lo Cascio, Tigran Margaryan, Ernesto Luna-Melendez, James B. McNamara, Connor I. White, William Knight, Saisrinidhi Ganta, Zorana Opachich, Claudia Cantoni, Wonsuk Yoo, Nader Sanai, Artak Tovmasyan, Shwetal Mehta
Rapid whole-brain myelin imaging with selective inversion recovery and compressed SENSE
Date: 03/2023
Authors: Ping Wang, Nicholas Sisco, Wonsuk Yoo, Aimee Borazanci, John Karis, J. P. Karis, John P Karis, Richard Dortch
Evaluation of two-stage designs of Phase 2 single-arm trials in glioblastoma: a systematic review
Date: 12/2022
Authors: Wonsuk Yoo, Seongho Kim, Michael Garcia, Shwetal Mehta, Nader Sanai
A Phase 0 Trial of Ceritinib in Patients with Brain Metastases and Recurrent Glioblastoma
Date: 01/2022
Authors: Shwetal Mehta, Roberto Fiorelli, Xun Bao, Chelsea Pennington-Krygier, Alanna Derogatis, Seongho Kim, Wonsuk Yoo, Jing Li, Nader Sanai
Human papillomavirus vaccine guideline adherence among Arizona's Medicaid beneficiaries
Date: 01/2021
Authors: Alexis Koskan, Lynne Klasko-Foster, Chad Stecher, Sue Rodriguez, Deborah Helitzer, Wonsuk Yoo